Eliminating health inequities in reproductive medicine: ensuring care for all

Plowden, Torie C.; Paulson, Richard J.

doi:10.1016/j.xfre.2022.04.002

Cited by 3 publications

(2 citation statements)

References 4 publications

(6 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…It is plausible that the few Black respondents may have been more likely to respond due to their dissatisfaction and discontinuation, and as a result, these responses may not be generalizable to the broader Black population of infertility patients. Of note, Plowden and Paulson 37 emphasized the dramatic disparities in health equity for Black and Native American patients that occur in gynecological health; ie, less successful outcomes in gynecological cancer 38 and inferior reproductive health outcomes. 39 As such, racial disparity continues in infertility care 37 and requires further investigation.…”

Section: Discussionmentioning

confidence: 99%

“…Of note, Plowden and Paulson 37 emphasized the dramatic disparities in health equity for Black and Native American patients that occur in gynecological health; ie, less successful outcomes in gynecological cancer 38 and inferior reproductive health outcomes. 39 As such, racial disparity continues in infertility care 37 and requires further investigation.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Identifying Factors Associated with Discontinuation of Infertility Treatment Prior to Achieving Pregnancy: Results of a Nationwide Survey

Collura,

Hayward,

Modrzejewski

et al. 2024

Journal of Patient Experience

View full text Add to dashboard Cite

The purpose of this mixed methods, cross-sectional patient survey was to characterize patient experience, to explore the frequency of and reasons for infertility treatment discontinuation and return to infertility treatments. Participants were recruited from United States patient support groups. Participants had received or were receiving ovulation induction (OI) with or without intrauterine insemination (IUI), with or without subsequent in vitro fertilization (IVF), or IVF with no other previous infertility treatment. Live birth was achieved by 62% of participants. Compared with participants treated with OI/IUI only, participants who underwent OI/IUI followed by ≥1 IVF cycle were less likely to consider discontinuing care (64% vs 77%; P = .014) or to discontinue treatment without achieving a pregnancy (40% vs 58%; P = .004). The most commonly cited reasons for treatment discontinuation were financial (62%) and psychological burden/treatment fatigue (58%). Expected versus actual time to pregnancy differed greatly. Continued desire for a child (60%) was the most frequently cited reason for continuing or resuming treatment. Expanded access to treatment, counseling and fostering realistic expectations regarding cumulative time to pregnancy may reduce treatment discontinuation.

show abstract